Physicians' Academy for Cardiovascular Education

Diabetic dyslipidaemia and residual risk in the era of LDL control

Mar. 21, 2016 - Boston, MA, USA - Aruna Pradhan

Video navigation menu

  • Addressing residual risk by lowering LDL in diabetic dyslipidaemia may not be enough 0:09
  • Insulin resistance affects lipid metabolism in diabetic patients 3:04
  • Are other lipid parameters better than LDL-c to identify residual risk in statin-treated patients? 5:29
  • Triglyceride-rich lipoproteins may be an important target 6:53
  • Data on triglyceride-lowering agents in outcome trials 8:41
  • Evaluating the CV effect of a PPAR agonist in T2DM patients in the planned PROMINENT trial 10:03